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While vaccines ensure individual protection against COVID-19 infection, delay in receipt or
refusal of vaccines will have both individual and community impacts. The behavioral factors
of vaccine hesitancy or refusal are a crucial dimension that need to be understood in order
to design appropriate interventions. The aim of this study was to explore the behavioral
determinants of COVID-19 vaccine acceptance and to provide recommendations to
increase the acceptance and uptake of COVID-19 vaccines in Bangladesh.
Methods
We employed a Barrier Analysis (BA) approach to examine twelve potential behavioral
determinants (drawn from the Health Belief Model [HBM] and Theory of Reasoned Action
[TRA]) of intended vaccine acceptance. We conducted 45 interviews with those who
intended to take the vaccine (Acceptors) and another 45 interviews with those who did not
have that intention (Non-acceptors). We performed data analysis to find statistically signifi-
cant differences and to identify which beliefs were most highly associated with acceptance
and non-acceptance with COVID-19 vaccines.
Results
The behavioral determinants associated with COVID-19 vaccine acceptance in Dhaka
included perceived social norms, perceived safety of COVID-19 vaccines and trust in them,
perceived risk/susceptibility, perceived self-efficacy, perceived positive and negative
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consequences, perceived action efficacy, perceived severity of COVID-19, access, and per-
ceived divine will. In line with the HBM, beliefs about the disease itself were highly predictive
of vaccine acceptance, and some of the strongest statistically-significant (p<0.001) predic-
tors of vaccine acceptance in this population are beliefs around both injunctive and descrip-
tive social norms. Specifically, Acceptors were 3.2 times more likely to say they would be
very likely to get a COVID-19 vaccine if a doctor or nurse recommended it, twice as likely to
say that most people they know will get a vaccine, and 1.3 times more likely to say that most
close family and friends will get a vaccine. The perceived safety of vaccines was found to be
important since Non-acceptors were 1.8 times more likely to say that COVID-19 vaccines
are “not safe at all”. Beliefs about one’s risk of getting COVID-19 disease and the severity of
it were predictive of being a vaccine acceptor: Acceptors were 1.4 times more likely to say
that it was very likely that someone in their household would get COVID-19, 1.3 times more
likely to say that they were very concerned about getting COVID-19, and 1.3 times more
likely to say that it would be very serious if someone in their household contracted COVID-
19. Other responses of Acceptors on what makes immunization easier may be helpful in
programming to boost acceptance, such as providing vaccination through government
health facilities, schools, and kiosks, and having vaccinators maintain proper COVID-19
health and safety protocols.
Conclusion
An effective behavior change strategy for COVID-19 vaccines uptake will need to address
multiple beliefs and behavioral determinants, reducing barriers and leveraging enablers
identified in this study. National plans for promoting COVID-19 vaccination should address
the barriers, enablers, and behavioral determinants found in this study in order to maximize
the impact on COVID-19 vaccination acceptance.
Introduction
As of 18 June 2021, there have been more than 177 million cases of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), or COVID-19, and more than 3.8 million deaths
have resulted from the pandemic in 224 countries [1]. The pandemic poses an immense threat
to the global public health system and is causing social and cultural disruptions [2, 3]. Bangla-
desh reported its first clinically-confirmed COVID-19 case on March 8, 2020, and as of 14
June 2021, Bangladesh has 826,922 COVID-19 confirmed cases with 13,118 deaths [4]. The
social and economic costs of COVID-19 have been significant in the developing countries like
Bangladesh [5]. As the pandemic is expected to continue to impose enormous burdens of mor-
bidity and mortality, and to severely disrupt societies and economies, the administration of
effective COVID-19 vaccines is the only clinical preventive measure [6]. As of 14 June 2021,
Bangladesh has administered 10,072,344 doses of Oxford/AstraZeneca (COVISHIELD) and
BIBP (SinoPhrama) vaccines in the whole country, out of which, 5,822,177 people have
received their 1st dose, and 4,250,167 have completed the two-dose schedule [4]. However,
like many other countries, the government has initially focused vaccination administration on
very specific groups of people with the general public expected to be eligible for vaccines at a
later date.
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Vaccine hesitancy or refusal around COVID-19 vaccines is a growing concern worldwide,
especially as new and deadly variants emerge. The World Health Organization (WHO) identi-
fied vaccine hesitancy as one of the top ten global health threats in 2019 [7] and hesitancy has
been a problem in COVID-19 vaccination, as well. A multi-country survey found that only
71.5% of participants reported that they would be very or somewhat likely to get a COVID-19
vaccine [8]. A rapid systematic review of 23 peer-reviewed studies and 103 additional syndi-
cated surveys around COVID-19 vaccine hesitancy in the US and globally showed that per-
ceived risk, concerns over vaccine safety and effectiveness, doctors’ recommendations, and
inoculation history were common influencing factors for vaccine hesitancy [9]. COVID-19
vaccine hesitancy was found to be growing between March and November 2020 [10], but
improvements in vaccine acceptance have been noted in some parts of the world since Novem-
ber [11]. In Bangladesh, one study reported around 81% of urban (metropolitan, district and
municipalities) people showed willingness to be vaccinated [12]. However, this study did not
report at what point in time (e.g., immediately, within six months) people were willing to be
vaccinated. Several studies reported a higher hesitancy or delay (around 32–42 percent) in
metropolitan areas of Bangladesh [13, 14] which is aligned with one nationally representative
survey [15]. Furthermore, more than a quarter of the population in Bangladesh are under 18
years of age [16] who were not yet eligible for COVID-19 vaccination at the time of this study.
Considering this, herd immunity will be even more difficult to achieve without very high vac-
cine acceptance among adults once a vaccine is available to a large portion of the population.
While COVID-19 vaccines ensure increased individual protection, with hesitancy and delay in
getting vaccines present among a higher proportion of people, it is critical to explore the rea-
sons for hesitancy in order to prevent community transmission [17]. Since vaccine hesitancy
for COVID-19 vaccines is relatively high, it is critical to explore the behavioral factors influenc-
ing it.
A growing number of studies have identified demographic, socioeconomic, and behavioral
factors that are linked with vaccine acceptance. These factors include age and marital status
[18, 19], level of education and ethnic origin [19–21], previous vaccination with the influenza
vaccine [20, 22], and gender [18]. Moreover, mistrust, misconceptions, misinformation, and
lack of knowledge among community members on vaccine-preventable diseases have been
considered influential determinants of lower levels of acceptance [8, 9, 20, 23, 24]. These fac-
tors have influenced vaccine uptake during previous pandemics and outbreaks caused by
H1N1, MERS, SARS, and Ebola virus [25–28].
A meta-analysis demonstrated that the use of behavioral change models (e.g. the HBM and
Theory of Planned Behavior) would be useful for identifying the influencing determinants of
vaccine acceptance [23]. The use of economic models when studying vaccine acceptance or
hesitancy exhibit some shortcomings in describing the determinants [23, 29, 30]. Behavioral
studies have shown that the decision to vaccinate is often based on perceived benefits, effec-
tiveness, and perceived risk of vaccine side-effects versus infection [31]. Systematic reviews on
behavioral determinants of health have shown that the HBM was useful in identifying determi-
nants associated with the acceptance of Human Papillomavirus (HPV) [29] and influenza vac-
cination uptake [32]. This model has also been found to be effective in predicting intention to
vaccinate against influenza among health care workers in Jordan [33]. Similarly, a study using
Theory of Planned Behavior (TPB) (which was developed from the TRA) showed that vaccine
intentions were determined by attitudes, subjective norms, and perceived behavioral control
regarding vaccinations among college students [34]. In a comparative study of TPB and TRA,
it was found that attitudes and perceptions of social support were determinants for HPV vacci-
nation uptake [30].
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Vaccine hesitancy and acceptance are complex in nature, and vaccine decisions can vary
according to context, time and place [35]. Global studies on demographic determinants can
have limited value when looking at determinants of COVID-19 vaccine acceptance in a given
country, time, and geographical area. The Technical Advisory Group on Behavioral Insights
and Sciences for Health of WHO has identified a number of behavioral drivers including
enabling environment, social influences and motivation, and recommended to contextualize
these drivers into national plans of COVID-19 vaccination [36]. Understanding how different
behavioral attributes affect individual preferences about vaccination at as granular level as fea-
sible can help inform public health authorities about the actionable activities and messages
that will be necessary to achieve broader community uptake of vaccines. Therefore, the pri-
mary objective of this study was to explore the behavioral determinants of COVID-19 vaccine
acceptance among people of different income levels in urban communities in Bangladesh. The
secondary objective of this study is to provide policy recommendations of culturally-acceptable
behavioral change intervention points to address these determinants in order to improve
COVID-19 vaccine uptake.
Materials and methods
Study site and context
This Barrier Analysis study was conducted in different urban areas of Dhaka from 9–15 Janu-
ary 2021. Dhaka is the capital city in Bangladesh and a residence for more than 10.3 million
people, or 6.29 percent of the total population of the country [37]. Between 8 March 2020 and
13 June 2021, there were 567,668 COVID-19 confirmed cases and 7,294 reported death in
Dhaka [4]. While Dhaka makes up about 6.29% of the total population of Bangladesh, almost
69% of the COVID-19 cases in Bangladesh were reported in Dhaka as of 13 June (59.0% in
Dhaka city alone) [4] making it one of the largest hotspots of COVID-19 [38].
Study tool
A Barrier Analysis (BA) study was conducted to better understand the behavioral determi-
nants of COVID-19 vaccine hesitancy in Dhaka. BA is a research tool that was developed in
1990 by Davis [39]. Based on HBM and TRA, BA studies explore respondents’ beliefs about a
behavior. Sometimes certain beliefs about a behavior (e.g., possible COVID-19 vaccination
side effects) are common in a population, but are not necessarily associated with vaccine
acceptance. BA is meant to identify the most likely behavioral determinants of a behavior [40].
A key feature of BA is that responses from those who have adopted a behavior or plan to
(‘Doers’ or ‘Acceptors’) are compared with those who are have not or do not plan to (‘Non-
doers’ or ‘Non-acceptors’) in order to identify behavioral determinants linked with a particular
behavior (e.g., handwashing with soap, getting a vaccine). This enables practitioners to develop
more effective behavior change messages and activities. BA has been used in more than 40% of
low-to-middle-income countries and used extensively by World Vision and other organiza-
tions during both the Ebola [41] and COVID-19 pandemics [42]. The beliefs and other
responses regarding behavioral determinants assessed during BA (see Table 1) are identified
with a focus on the most actionable findings. The other details of BA approach can be found
elsewhere [43–48]. There are BA studies in the peer-reviewed literature on exclusive breast-
feeding [49], handwashing with soap at critical times [43], timely oral polio vaccination and
agricultural extension behaviors [50], dietary salt reduction [51], transition from the lac-
tational amenorrhea method to other modern family planning methods [39] and cervical can-
cer screening [52].
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Questionnaire development
This study modified the standardized Barrier Analysis questionnaire from the Designing for
Behavior Change (DBC) training manual [48].
The BA questionnaire is divided into three parts (Please see S1 File) In the first section,
three questions were asked in order to categorize the potential respondents either an ‘Accep-
tor’ or a ‘Non-acceptor’ of COVID-19 vaccine. Specifically, we asked their age, and–if a
COVID-19 vaccine was available to them in the coming months–how likely they would be to
go for vaccination. The second section included four questions on their demographic
Table 1. The Generic description of the determinants [40] and contextualization for the current study.
Name of
determinant
Generic description Contextualization for the current study.
Perceived self-
efficacy
An individual’s belief that he/she can do a particular behavior given
his/her current knowledge, resources and skills.
We asked the respondents what might make it easier and what might
make it difficult for them to get a COVID-19 vaccine if it was available to
them in the coming month free of charge.
Perceived social
norms
The perception that people important to an individual think that
he/she should do the behavior (injunctive norms), and plan to do
the behavior (descriptive norms).
We asked respondents:
• what portion of the people they know did they think would get a
COVID-19 vaccine if was available to the community in the coming
month free of charge;
• if their close family and friends would want them to get a COVID-19
vaccine;
• if their community and religious leaders would want them to get a
COVID-19 vaccine;
• who would approve of them getting a COVID-19 vaccine;
• who would disapprove of COVID-19 vaccination;




What positive things a person thinks will happen as a result of
performing a behavior.




The negative things a person thinks will happen as a result of
performing a behavior.
We asked respondents about the disadvantages of getting a COVID-19
vaccine.
Access The degree of availability (to a particular audience) of the needed
facilities, services, or materials required to adopt a given behavior.
We asked the respondents how difficult it would be for them to get to the
clinic where vaccines are normally offered.
Cues to action /
reminders
The presence of reminders that help a person remember to do a
particular behavior.
Questions on this possible determinant were not included in the current




A person’s perception of how vulnerable or at risk they feel vis-à-vis
the problem or disease.
Respondents were asked what portion of people in their community have
had COVID-19, how likely they thought it was that someone in their
household would contract COVID-19, and how concerned they were
about getting COVID-19.
Perceived severity Belief that the problem or disease (which the behavior can prevent)
is serious.
Respondents were asked how serious it would be if someone who lives in
their household contracted COVID-19.
Perceived action
efficacy
The belief that by practicing the behavior one will avoid the
problem or disease; that the behavior is effective in preventing the
problem or disease.
Respondents were asked if they were to get the COVID-19 vaccine, how
likely would it be that they would get COVID-19 disease after that.
Perceived divine will A person’s belief that it is God’s / Allah’s or the gods’ will
(depending on their faith) for him/her to have the problem and/or
to overcome it.
Respondents were asked if they thought that Allah / God / the gods
approved or disapproved of people getting a COVID-19 vaccine. There
were also asked if they agreed with the statement, “Whether I get COVID-
19 or not is purely a matter of God’s will or chance. The actions I take will
have little bearing on whether or not I get COVID-19.”
Policy Laws and regulations (local, regional, or national) that affect
adoption of the behavior and access to products and services.
Omitted from the study as the Government has decided to vaccinate its
population and started vaccination program.
Culture The set of history, customs, lifestyles, values, and practices within a
self-defined group.
Respondents were asked if there were any cultural or religious reasons
that they would not get a COVID-19 vaccine, and if yes, what those
reasons were.
https://doi.org/10.1371/journal.pone.0256496.t001
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background, specifically on the respondents’ age, gender, level of education and profession.
The third section included determinant-specific questions. Based on the nature of determi-
nant, both close-ended and open-ended questions were used to assess 10 of the usual 12 deter-
minants of BA [40, 47]. Trust on vaccine information (provided by government officials,
political, religious and community leaders), trust in vaccines, exposures to misinformation,
and safety and efficacy of the vaccine are considered as important factors in vaccine acceptance
in previous studies [8, 53–55], so questions on these factors were explored in this study, a well.
Moreover, a previous study using BA method in the Ebola Vaccine Deployment and Compli-
ance Project [41] found important insights by exploring these factors. In addition, based on
local social media listening, one question was added to explore respondents’ beliefs about herd
immunity. The questionnaire was pretested among 12 respondents (6 acceptors and 6 non-
acceptors) to check suitability of the language and slight modifications were made. (The
responses from this pre-test were excluded from the current analysis.) After completing the
pretest, modifications were made into Bengali version and those modifications were translated
back into the English version.
Sampling
The Barrier Analysis approach recommends a minimum sample size of 45 Doers (Acceptors)
and 45 Non-doers (Non-acceptors) in order to detect statistically-significant Odds Ratios of
3.0 or higher with an alpha error of 5% and a power of 80% [40]. We interviewed adult men
and women for this BA study and selected them through a convenience sampling strategy
from six different areas of Dhaka, the capital city of Bangladesh. Enumerators from these six
wards chose a starting household near where they lived, and then went door-to-door to iden-
tify respondents based on the questionnaire logic. Each enumerator was given a quota of 7 or 8
Acceptors and 7 or 8 Non-acceptor for a total of 15 respondents each.
Data collection, management and analysis
We collected data from 9 to 13 January 2021 through individual interviews with responses
recorded on paper-based questionnaires by three teams composed of one female and one male
member. Male enumerators interviewed male respondents, and female enumerators inter-
viewed female respondents. A research supervisor assured the quality of data. Following data
collection, the data collection team and the lead author coded the open-ended responses the-
matically, using both an inductive and deductive coding process. At the end of this process,
the team quantified the responses in each category for Acceptors and Non-acceptors sepa-
rately. These categories and the number of responses registered for each were then entered
into a standardized BA tabulation sheet that revealed whether differences in the proportion of
Acceptors and Non-acceptors providing each response were statistically significant and should
be addressed through the behavior change strategy. For each question and category of
responses, the BA tabulation calculates the percentage of responses for both Acceptors and
Non-Acceptors; the Odds Ratio, the Standard Error, and its confidence interval; the Estimated
Relative Risk (ERR) [56]; and p-values (see S2 File). This allows practitioners to identify those
differences between Acceptors and Non-acceptors that are statistically significant (at p<0.01)
and to see the strength of the associations between each response and the behavior (based on
the ERR).
Ethical considerations
We performed all procedures in this study in accordance with the ethical standards of the insti-
tutional and national research committee and with the 1964 Helsinki Declaration and its later
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amendments or comparable ethical standards. The study protocol was approved by the institu-
tional Ethics Committee of the Chattogram Veterinary and Animal Sciences University, Ban-
gladesh (permit ref. no. CVASU/Dir (R and E) EC/2020/169). We informed respondents
about the study objectives, and obtained their written consent before conducted interview.
The data collection activities were performed following the COVID-19 safety protocols in Ban-
gladesh that were enacted by the Directorate General of Health Services in Bangladesh [57].
Results
Respondents’ demographic profile
The characteristics of the study interviewees are shown in Fig 1. The majority of the respon-
dents were male (71% and 58% of acceptors and Non-acceptors, respectively), and most of
them belonged to the 18–25 years of age group (29% and 29% respectively). In terms of educa-
tional attainment, the majority of the respondents had completed education until 10th grade
(36% and 49% of Acceptors and Non-acceptors, respectively) while most worked in services
followed by small business.
Determinant specific results
The statistically significant differences in responses and beliefs were found between Acceptors
and Non-acceptors of COVID-19 vaccine are shown below. The categories of determinants
are organized from higher to lower estimated relative risk (ERR). The detailed results are pro-
vided in the S2 File.
Perceived social norms. Some of the strongest predictors of vaccine acceptance in this
population are beliefs around both injunctive and descriptive social norms: who the respon-
dent thinks approves or disapproves of COVID-19 vaccination, and the proportion of people
that they think will go for a COVID-19 vaccine when it is available. The results are shown in
Table 2. Specifically, Acceptors were 3.2 times more likely to say they would be “very likely” to
get a COVID-19 vaccine if a doctor or nurse approved (p<0.001), while Non-acceptors were
2.6 more likely to say it would be “not likely” that they would get a vaccine if a doctor or nurse
recommended it (p<0.001). Acceptors were almost twice as likely to say that “most people”
they know will get a vaccine (p<0.001), and 1.3 times more likely to say that “most close family
and friends” will get a vaccine (p = 0.003). Conversely, Non-acceptors were 3.5 times more
likely to say that “very few people” they knew would get a vaccine (p<0.001) and 1.3 times
Fig 1. Respondents’ demographic profile.
https://doi.org/10.1371/journal.pone.0256496.g001
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more likely to say that “most of their close family and friends” would not get a COVID-19 vac-
cine (p = 0.003). In terms of respondents’ impressions concerning who disapproves of their
getting a COVID-19 vaccine, Acceptors were 1.7 times more likely (than Non-acceptors) to
say that “no one” would disapprove (p<0.001). Non-acceptors were 1.5 times more likely to
say that “my mother” (p<0.001), 1.4 times more likely to say “elderly people” (p = 0.009), and
1.7 times more likely to say “people who will not get the vaccine” (p = 0.006) would disapprove
of their getting a COVID-19 vaccine. In addition, Acceptors were 1.3 times more likely to say
their mother would approve of their getting a COVID-19 vaccine (p<0.001). With regards to
community and religious leaders’ influence on the decision to get a COVID-19 vaccine,
Acceptors were 1.3 times more likely to say that “most community and religious leaders”
would want them to get a vaccine (p = 0.007), while Non-acceptors were 1.5 times more likely
to say that most community leaders and religious leaders would not want them to get a
COVID-19 vaccine (p = 0.002).
Perceived safety of COVID-19 vaccines. As in many places in the world, concerns about
the safety of COVID-19 vaccines are affecting COVID-19 vaccination acceptance in this popu-
lation. When asked how safe the COVID-19 vaccines are, Non-acceptors were 1.8 times more
likely to say that COVID-19 vaccines are “not safe at all” (p<0.001) while Acceptors were 1.4
times more likely to say that COVID-19 vaccines are “mostly safe” (p<0.001) (Table 3).
Perceived self-efficacy. The respondents were asked two open-ended questions to under-
stand what they believe might make it easier or difficult to get a COVID-19 vaccine once it was
available to them free of charge. From the results (Table 4), factors related to how and where





Diff.� Odds Ratio 95% CI ERR�� p-value
Will you get a COVID-19 vaccine if doctor or nurse recommends?
Very likely 42 (93) 14 (31) 62% 31 8.19–117.28 3.18 <0.001
Somewhat likely 3 (7) 20 (44) -38% 0.09 0.02–0.33 0.44 <0.001
Not likely at all 1 (2) 9 (20) -18% 0.09 0.01–0.75 0.38 0.008
Proportion of people you know will get vaccine?
Most people would get the vaccine 38 (84) 12 (27) 58% 14.93 5.26–42.33 1.96 <0.001
Very few people would get it 1 (2) 13 (29) -27% 0.06 0.01–0.45 0.29 <0.001
Will most of your close family and friends would want you to get a COVID-19 vaccine?
Yes 32 (71) 18 (40) 31% 3.69 1.53–8.89 1.31 0.003
No 10 (22) 22 (49) -27% 0.3 0.12–0.75 0.76 0.007
Who disapproves to take a COVID-19 vaccine?
No one disapproves 32 (71) 3 (7) 64% 34.46 9.05–131.22 1.72 <0.001
Who approves to take a COVID-19 vaccine?
Mother 18 (40) 5 (11) 29% 5.33 1.77–16.1 1.27 0.002
The people who will not take the vaccine 3 (7) 13 (29) -22% 0.18 0.05–0.67 0.58 0.006
Elderly member/relatives 7 (16) 18 (40) -24% 0.28 0.1–0.75 0.73 0.009
The people who will not take the vaccine 3 (7) 13 (29) -22% 0.18 0.05–0.67 0.58 0.006
Will most of your community leaders and religious leaders want you to get a COVID-19 vaccine?
Yes 35 (78) 23 (51) 27% 3.35 1.34–8.35 1.31 0.007




PLOS ONE Behavioral determinants of COVID-19 vaccine acceptance in Dhaka, Bangladesh
PLOS ONE | https://doi.org/10.1371/journal.pone.0256496 August 23, 2021 8 / 20
the vaccine would be given affects intention to vaccinate, including whether or not proper
COVID-19 social distancing and prevention measures are maintained during vaccination.
Concerning what might make it easier, Acceptors were 1.4 times more likely to say “if vacci-
nation is provided by government health care centers or hospitals” (p<0.001), 1.2 times more
likely to say “school-based vaccination centers” (p = 0.003), 1.3 times more likely to say “if the
vaccines are provided by establishing kiosks” (p = 0.001) and 1.2 times more likely to say “if
proper health and safety (COVID-19) protocols are maintained while giving the vaccine”
(p = 0.006). Non-acceptors were 1.2 times more likely to say “when vaccines are given at
home” (p = 0.010), and 1.7 times more likely to say “if the vaccine has no side effects”
(p = 0.002) would make it easier for them to get a COVID-19 vaccine.
When asked what might make it difficult to get a COVID-19 vaccine, Acceptors were 1.3
times more likely to say either “if there are no health measures in the vaccination center due to
overcrowding” or “risk of getting infected with COVID-19 while vaccinating” (p = 0.001), and
1.2 times more likely to say “if the vaccinator does not follow proper COVID-19 preventive
measures” (p = 0.005) would make it difficult to get a COVID-19 vaccine. Non-acceptors were
2.4 times more likely to say “if the vaccine has severe side-effects” (p<0.001) and 2 time more
likely to say “if there is bribery” (p = 0.004) would make it difficult to get a COVID-19 vaccine.
Table 3. Perceived safety and risk.
Determinants/response Doers n (%) Non-Doers n (%) Diff. Odds Ratio 95% CI ERR p-value
Safety: How safe would it be for you to get a COVID-19 vaccine?
Not safe at all 7 (16) 28 (62) -47% 0.11 0.04–0.31 0.57 <0.001
Mostly safe 26 (58) 8 (18) 40% 6.33 2.41–16.6 1.36 <0.001
https://doi.org/10.1371/journal.pone.0256496.t003








95% CI ERR p-value
Self-Efficacy: What would make it easier?
If vaccine is provided by government health centers or hospitals 23
(51)
5 (11) 40% 8.36 2.79–
25.08
1.36 <0.001
School-based vaccination centers 21
(47)
8 (18) 29% 4.05 1.55–
10.60
1.25 0.003
If the vaccines are provided by establishing kiosks 18
(40)
4 (9) 31% 6.83 2.08–
22.40
1.29 0.001
If proper health and safety (COVID-19) protocols are maintained while giving vaccine 20
(44)
8 (18) 27% 3.7 1.41–
9.70
1.23 0.006
If the vaccines are given at home 15
(33)
27 (60) -27% 0.33 0.14–
0.79
0.8 0.010
When the vaccines do not have any side effects 4 (9) 16 (36) -27% 0.18 0.05–
0.58
0.6 0.002
Self-Efficacy: What would make it Difficult?
If there are no health measures in the vaccination center due to overcrowd (or risk of getting
infected with COVID-19 while vaccinating).
18
(40)
4 (9) 31% 6.83 2.08–
22.4
1.29 0.001
If the vaccinator does not follow proper COVID-19 preventive measures 19
(42)
7 (16) 27% 3.97 1.46–
10.8
1.24 0.005
When the vaccine has severe side-effects 3 (7) 22 (49) -42% 0.07 0.02–
0.28
0.41 <0.001
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Perceived positive consequences and perceived negative consequences. Respondents
were also asked what the positive and negative consequences (e.g., advantages and disadvan-
tages) would be of getting a COVID-19 vaccine (Table 6). Acceptors were more likely to men-
tion (as advantages of COVID-19 vaccination) reducing the risk of COVID-19 infection and
benefits related to livelihoods, and re-starting economic activities and getting back to normal
life. Specifically (Table 5), Acceptors were 1.3 times more likely to say that reducing the risk of
COVID-19 infection (p = 0.003), 1.3 times more likely to say “we can attend social and cultural
activities” (p = 0.003), 1.2 times more likely to say “children can start school again” (p = 0.003),
1.3 times more likely to mention “reduction in COVID-19 related costs” (e.g. masks, hand
sanitizer, tests; p<0.001), 1.3 times more likely to say “employment and income opportunities
will be increased” (p<0.001), and 1.3 times more likely to say “attending prayers in congrega-
tion” (p<0.002) as advantages of getting a COVID-19 vaccine.
When asked about the negative consequences (disadvantages) of COVID-19 vaccination,
Acceptors were 1.3 times more likely to mention mild side effects of vaccination such as
“weakness” (p<0.002) and “itching and skin problems” p<0.001). Meanwhile, Non-acceptors
were 1.6 times more likely (than Acceptors) to mention life-threatening side effects (p<0.001),
1.5 times more likely to say “unknown/new diseases” (p<0.004), and 1.9 times more likely to
say “infertility” (p<0.001) as disadvantages of getting a COVID-19 vaccine.
Perceived action efficacy. Counter-intuitively, Acceptors were 1.3 times more likely to
say they were “somewhat likely” to get COVID-19 once they were vaccinated against it
(p<0.001) while Non-acceptors were 2.8 times more likely to say that they were “not likely at
all” to get COVID-19 once one was vaccinated against it (p<0.001) (Table 6). Focus group dis-
cussions may be used at a later point in time to explore this finding. Related to herd immunity,







95% CI ERR p-value
Perceived Positive Consequences (Advantages)
Reduce the risk of COVID infection 30 (67) 16 (36) 31% 3.63 1.52–
8.65
1.29 0.003
Children can start school again 17 (38) 5 (11) 27% 4.86 1.6–14.7 1.25 0.003
Reduction in COVID-19-related costs (mask, hand sanitizer, detergents, primary
medicine, COVID-19 test, etc).
16 (36) 3 (7) 29% 7.72 2.06–
28.9
1.28 0.001
We can attend social and cultural activities 14 (31) 3 (7) 24% 6.32 1.67–
23.9
1.25 0.003
New employment/income sources will be increased 17 (38) 3 (7) 31% 8.5 2.28–
31.7
1.3 <0.001
Attend prayers in congregation 16 (36) 4 (9) 27% 5.66 1.71–
18.7
1.26 0.002
No positive outcome 0 5 (11)
Perceived Negative Consequences (Disadvantages)
Weakness 23 (51) 9 (20) 31% 4.18 1.64–
10.7
1.27 0.002
Itching and skin problem 17 (38) 3 (7) 31% 8.5 2.28–
31.7
1.3 0.000
Life threatening side effects 7 (16) 24 (53) -38% 0.16 0.06–
0.44
0.63 0.000
Unknown/new diseases 6 (13) 18 (40) -27% 0.23 0.08–
0.66
0.68 0.004
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respondents were asked if they agree or disagree with the statement “If one has been infected
with COVID-19, vaccination with the COVID-19 vaccine is unnecessary.” The Non-Acceptors
were 1.8 times more likely to ‘agree a little’ with this statement. Related to perceived action effi-
cacy, and to explore beliefs on herd immunity, respondents were asked if they agreed or dis-
agreed with the statement “Most people will eventually get infected with COVID-19, so getting
a COVID-19 vaccine is unnecessary.” Non-acceptors were 1.7 times more likely to say that
they “agree a little” and “agree a lot” with the statement (p<0.001) while Acceptors were 1.5
times more likely to “disagree a lot” with the statement (p<0.001).
Trust in COVID-19 vaccines. As expected, trust in COVID-19 vaccines is highly predic-
tive of intended vaccine acceptance in Dhaka. Acceptors were twice as likely to say that they
trust the COVID-19 vaccines “a lot” or a “moderate amount” (p<0.001). Conversely, Non-
acceptors were 1.7 times more likely to say that they “trust them a little” (p<0.001) and 2.3
times more likely to say that they “do not trust [COVID-19 vaccines] at all” (p = 0.001)
(Table 6).
Perceived risk / susceptibility (to COVID-19). Perceived risk of getting COVID-19 and
the level of concern about getting COVID-19 also appeared to be highly predictive of intended
vaccine acceptance in Dhaka. Acceptors were 1.4 times more likely to say they it was “very
likely” that someone in their household would get COVID-19 over the next 3 months
(p<0.001) while Non-acceptors were 1.3 times more likely to say that was only “somewhat
likely” (p = 0.005). When respondents were asked how concerned they were about someone in
their household getting COVID-19, Acceptors were 1.3 times more likely to say that they were
“very concerned” (p = 0.002) while Non-acceptors were 1.7 times more likely to say that they
were only “a little concerned” (p<0.001). Additionally, Non-acceptors were 1.7 times more
likely to say that “very few people” have had COVID-19 in their communities (p<0.001)
(Table 7).
Perceived severity (of COVID-19). The perceived severity of COVID-19 was also predic-
tive of intended vaccine acceptance. Respondents were asked how serious it would be if they
or someone else in their household got COVID-19. Acceptors were 1.3 times more likely (than
Non-acceptors) to say that it would be “very serious” (p = 0.001) (Table 7).
(Perceived) access. Perceived difficultly in reaching clinics that normally provide vaccines
was predictive of intended COVID-19 vaccine acceptance in Dhaka. Non-acceptors were 1.6
times more likely to say that it was “very difficult” to get to the facility that normally provides
Table 6. Perceived action efficacy and trust in COVID-19 vaccine.
Determinants/response Doers n (%) Non-Doers n (%) Diff. Odds Ratio 95% CI ERR p-value
Action Efficacy—Likelihood of getting COVID-19 after getting COVID-19 vaccine?
Somewhat likely 22 (49) 6 (13) 36% 6.22 2.2–17.6 1.31 <0.001
Not likely at all 2 (4) 19 (42) -38% 0.06 0.01–0.3 0.35 <0.001
Perception on herd immunity: If one has been infected with COVID-19, vaccination with the COVID-19 vaccine is unnecessary.
Agree a little 9 (20) 20 (44) -24% 0.31 0.12–0.80 0.76 0.012
Most people will eventually get infected with COVID-19, so getting a COVID-19 vaccine is unnecessary.
Agree a little / Agree a lot 8 (18) 29 (64) -47% 0.12 0.04–0.32 0.60 <0.001
Trust (in COVID-19 vaccine)—How much would you trust a COVID-19 vaccine?
Trust it a moderate amount 19 (42) 6 (13) 29% 4.75 1.67–13.5 1.26 0.002
Trust it a lot 18 (40) 2 (4) 36% 14.33 3.08–66.7 1.34 <0.001
Do not trust it at all 2 (4) 14 (31) -27% 0.1 0.02–0.49 0.44 0.001
Trust it a little 6 (13) 23 (51) -38% 0.15 0.05–0.42 0.6 <0.001
https://doi.org/10.1371/journal.pone.0256496.t006
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vaccines (p<0.001), while Acceptors were 1.3 times more likely to say it was “somewhat diffi-
cult” to get to that facility (p<0.001) (Table 7).
Perceived divine will. Personal agency and religious beliefs often come into play with vac-
cine acceptance. In this study (Table 8), we assessed personal agency around COVID-19 infec-
tion by asking respondents’ degree of agreement or disagreement with the statement,
“Whether I get COVID-19 or not is purely a matter of God’s will or chance, the actions I take
will have little bearing on whether or not I get COVID-19.” Agreement with this statement
was found to be predictive of vaccine acceptance. Specifically, Acceptors were 1.2 times more
likely to say that they “disagree a lot” (p = 0.005) with this statement. We asked the respon-
dents whether they believed that Allah, God, or the gods approves or disapproves of people
getting COVID-19 vaccines. While 80% of Acceptors and 78% of Non-acceptors said that a
deity approved of COVID-19 vaccinations, there were no statistically significant differences
between Acceptors and Non-acceptors for this question (S2 File).
Rumors/ culture. Respondents were asked if there were any cultural or religious reasons
that they would not get a COVID-19 vaccine (Table 8). Acceptors were 1.3 times more likely
to say that there were no cultural or religious reasons they would not get a COVID-19 vaccine
(p = 0.01), while Non-acceptors were 1.3 more likely to say that there were reasons (p = 0.002).





Diff. Odds Ratio 95% CI ERR p-value
Perceived Risk / Susceptibility—Likelihood of someone in your household getting COVID-19 over next 3 months?
Very likely 25 (56) 4 (9) 47% 12.81 3.92–41.83 1.43 <0.001
Somewhat likely 11 (24) 24 (53) -29% 0.28 0.12–0.69 0.76 0.005
Perceived Risk / Susceptibility—How concerned are you about getting COVID-19?
Very concerned 22 (49) 8 (18) 31% 4.42 1.69–11.6 1.27 0.002
A little concerned 5 (11) 21 (47) -36% 0.14 0.05–0.43 0.57 <0.001
Perceived Risk / Susceptibility—Proportion of people in your community who have had C-19?
Very few people. 4 (9) 17 (38) -29% 0.16 0.05–0.53 0.58 0.001
Severity—How serious if someone in your HH got COVID-19?
Very serious 27 (60) 12 (27) 33% 4.13 1.69–10.1 1.3 0.001
Access—How difficult for you to get to the clinic where vaccines are normally offered?
Very difficult 8 (18) 28 (62) -44% 0.13 0.05–0.35 0.61 <0.001
Somewhat difficult 20 (44) 5 (11) 33% 6.4 2.13–19.23 1.3 <0.001
https://doi.org/10.1371/journal.pone.0256496.t007
Table 8. Perceived divine will and culture/rumors.
Determinants/response Doers n (%) Non-Doers n (%) Diff. Odds Ratio 95% CI ERR p-value
Divine Will—Agree/disagree with "whether I get COVID-19 or not is purely a matter of God’s will or chance.
Disagree a lot 26 (58) 13 (29) 29% 3.37 1.4–8.08 1.25 0.005
Culture—Any cultural or religious reasons you would not get COVID-19 vaccine?
No 30 (67) 18 (40) 27% 3 1.27–7.09 1.25 0.010
Yes 11 (24) 25 (56) -31% 0.26 0.11–0.64 0.74 0.002
(If yes to Culture) What reasons
Use of pork fat while making vaccine–Islam does not allow this. 5 (11) 19 (42) -31% 0.17 0.06–0.51 0.61 0.001
Use of haram ingredients in the vaccine 8 (18) 21 (47) -29% 0.25 0.09–0.65 0.71 0.003
If yes to (rumors) What would stop you or others from seeking the vaccine?
Producers’ hide and seek activities related to vaccine accuracy in the clinical test 16 (36) 4 (9) 27% 5.66 1.71–18.7 1.26 0.002
https://doi.org/10.1371/journal.pone.0256496.t008
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When asked what those reasons were, Non-Acceptors were 1.6 more likely to say that they had
heard that ‘the vaccines were made with pork fat which is not allowed (haram) by Islam’
(p = 0.001) and 1.4 times more likely to say that ‘vaccines were made with haram ingredients’
(p = 0.003). Respondents were also asked if they had seen or heard of anything that would stop
them or others from seeking to get a COVID-19 vaccine. If they said yes, they were asked a fol-
low-up question on what would stop them or others from seeking the vaccine. Regarding this
question, Acceptors were 1.3 more likely to say that producers’ “hide and seek activities”
related to vaccine accuracy in the clinical testing would stop them or their peers from getting a
COVID-19 vaccine (p = 0.002). By hide and seek activities of vaccine producers, the respon-
dents were referring to perceived misinformation and incomplete information being given on
clinical trials and the process of developing a safe vaccine.
Discussion
This Barrier Analysis study on intended acceptance of COVID-19 vaccines revealed important
differences in responses and beliefs between Acceptors and Non-acceptors regarding behav-
ioral determinants of vaccine acceptance in this urban setting of Bangladesh. One important
finding is that even if one or two determinants or barriers are addressed, there are a multitude
of important determinants and barriers that may affect vaccine acceptance, and deserve atten-
tion. Access, for instance, was among other determinants found to be important in our study
in along with perceived social norms (found to be important in 75% of all BA studies in a
recent review) and positive/negative consequences of the behavior (found to be important in
56% of all BA studies in that review) [58].
The largest potential predictor and behavioral driver of COVID-19 vaccine acceptance in
this population, based on the associations seen between responses and vaccine acceptance, was
perceived social norms. Perceived social norms, depending on the context, may hinder or
inspire one to get a vaccine [59]. In this study, Acceptors were more likely (than Non-accep-
tors) to say that most people they know and most of their close family and friends will get the
COVID-19 vaccine, that no one would disapprove of their getting a vaccine, and that they
would be very likely to get a vaccine if a doctor or nurse recommended it. Similarly, one sys-
tematic review showed health care professionals are influential in promoting vaccinations
[60], and our study confirmed this, as well. Acceptors were also more likely to say that most of
their community and religious leaders will want them to get a vaccine.
Other beliefs, for example safety and trust, about the vaccines themselves were important,
as well [61, 62]. In this study, Non-acceptors were much more likely to say that COVID-19
vaccines are “not safe at all” and to say that they only “trust them a little.” Conversely, Accep-
tors were more likely to say that the COVID-19 vaccines are “mostly safe” and to say that they
trust them “a lot.”
In line with the Health Belief Model, beliefs about the disease itself were highly correlated
with–an predictive of–vaccine acceptance [29]. Acceptors were much more likely (than Non-
acceptors) to say it was “very likely” that someone in their household would get COVID-19
over the next three months and to be “very concerned” about getting COVID-19. Conversely,
Non-acceptors were much more likely to say that it would be only “somewhat likely” that
someone in their household would get COVID-19 and that “very few people” have had
COVID-19 in their community. In alignment with what Patrick et al. [63] showed regarding
perceived risk as structural feature of vaccine decision, Acceptors of this study were also more
likely to believe that it would be “very serious” if someone in their household got COVID-19.
Perceived behavioral control (which is influenced by things that make it difficult or easy to
perform the behavior) also influence vaccine uptake [34]. The barriers and enablers which
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were mentioned more often by Acceptors provide clues as to ways to make it easier to boost
acceptance. When asked what would make it easier to get a COVID-19 vaccine, Acceptors
were more likely (than Non-acceptors) to mention providing vaccination through government
health facilities, schools, and kiosks, and having vaccinators maintain proper COVID-19
health & safety protocols. Responding to the question about what would make it difficult to get
a COVID-19 vaccine, Non-acceptors were much more likely say “when the vaccine has severe
side effects.” Personal agency also came into play: Acceptors were much more likely to say that
they did not believe that getting COVID-19 was purely a matter of God’s will or chance.
Aligned with other studies on vaccination uptake [64, 65], the results of this study showed
that perceived effects of vaccines are a key factor in the vaccine decision. Acceptors named sev-
eral positive consequences of getting a COVID-19 vaccine more often than Non-acceptors
including (1) reduced the risk of Covid-19 infection, (2) being able to attend social and cultural
activities, (3) children being able to start school again, (4) reduction in COVID-19 related
costs, (5) increased employment and income opportunities, and (6) being able to attend pray-
ers in a group setting. Conversely, Non-acceptors asked about negative consequences of get-
ting a COVID-19 vaccine were more likely to mention (than Acceptors) (1) life-threatening
side effects, (2) developing unknown / new diseases, and (3) becoming infertile as disadvan-
tages that they would expect if they were to get a COVID-19 vaccine. Surprisingly, Acceptors
were 1 more likely to say they were “somewhat likely” to get COVID-19 once they were vacci-
nated against it (p<0.001) while Non-acceptors were more likely to say that they were “not
likely at all” to get COVID-19 if they were vaccinated.
Lastly, Non-acceptors were more likely to hold beliefs about herd immunity that could
reduce acceptance, saying that they agree a little or a lot with the statement that “most people
will eventually get infected with COVID-19, so getting a COVID-19 vaccine is unnecessary”.
Limitations
This study has a number of limitations. First, given that this study was only done in a limited
urban area, the results should not be generalized to the rest of Bangladesh or other countries.
The results are most generalizable to the six wards where interviews were conducted, but may
be useful for other parts of Dhaka Second, by design (as a means to make the analysis easier for
practitioners and the method replicable by more practitioners), the BA approach does not con-
sider respondents’ socio-economic information including level of income, living conditions,
or other factors which may lead to some confounding or interaction of variables. Third, while
the questionnaire was based on a standard questionnaire which has been used in hundreds of
BA studies, and pretested with about 12 respondents, the questionnaire did not undergo for-
mal reliability checks (e.g., inter-rater reliability). For the same reasons, probably, the analysis
revealed wider confidence intervals. Finally, while many current studies recognize that there is
a spectrum of acceptance between those who accept, those who are undecided or hesitant, and
those who refuse, for the purposes of this study and for ease of analysis, we defined vaccine
acceptance in a binary way.
Implications for behavior change strategy
With these limitations aside, the study has a number of merits that make it useful in designing
an integrated behavior change strategy to increase acceptance of COVID-19 vaccines. Aligned
with WHO’s Technical Advisory Group on Behavioral Insights and Sciences for Health rec-
ommendation on social and behavioral drivers on COVID-19 vaccination [36], our study
identified important beliefs and responses associated with different determinants of COVID-
19 vaccine acceptance among urban population in Bangladesh which could be valuable to
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informing contextualized behavioral intervention and engagement strategies to support
COVID-19 vaccination. For example, to increase perceived positive social norms, especially
for those who found to be important influencers of this behavior (e.g., medical staff and moth-
ers), videotaping individuals giving testimonials in each neighborhood on why they plan to get
the vaccine, and distributing them over media is one possible approach to leverage social
norms. Other activities can be used to make acceptance more visible (e.g., stickers on house-
holds that say, “We plan to vaccinate!” or lapel pins with the same message). To increase the
perception that COVID-19 is serious (to address low perceived severity), testimonials by peo-
ple who have lost or almost lost family members due to COVID-19 disease could be used. To
address perceived divine will, religious leaders of all faiths could be assisted in creating sermon
outlines on maintaining one’s health (and linking that with COVID-19 vaccines), and sup-
ported in creating radio spots to promote COVID-19 vaccines. In addition to prevention of
COVID-19, other positive consequences of immunization mentioned more often by Acceptors
should be disseminated. While not repeating any misinformation, it will be important to pro-
vide clear information on the known minor risks of COVID-19 vaccination as a way to combat
misinformation on side effects that were mentioned more often by Non-acceptors (e.g., life-
threatening conditions, new diseases, infertility). Clear and detailed information on how vac-
cines are made and tested should be disseminated to counter misinformation (e.g., that vac-
cines are made with pork fat or other haram ingredients). Stakeholders should also take into
account the findings on things that may make vaccination easier for people, such as providing
the vaccine in schools and kiosks (in addition to government health facilities) and to assure
that the population understands that proper COVID-19 health and safety protocols will be
maintained in places where vaccines are given.
Conclusion
This BA study has revealed a host of important behavioral determinants associated with and
predictive of intended COVID-19 vaccine acceptance among the study population in Dhaka,
Bangladesh. Particularly, perceived social norms, and beliefs about safety and trust in COVID-
19 vaccines, perceived risk of getting COVID-19 and severity of the disease, perceived action
efficacy, and personal agency are predictive of COVID-19 vaccination seeking among this
study population. Findings on these potential behavioral drivers of COVID-19 vaccination
acceptance should be used in the development of vaccination and communication plans. The
study also has uncovered some important beliefs on the positive consequences from both
Acceptors and Non-acceptors, which could be leveraged in developing behavior change mes-
sages. The results suggest that an integrated behavior change strategy, focused broadly on the
behavioral determinants found to be associated with vaccine acceptance and hesitancy, needs
to be incorporated into existing vaccination plans to increase the acceptance and uptake of
COVID-19 vaccines and to end the pandemic.
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